Goodwin Procter advised ACELYRIN on the deal. ACELYRIN announced the completion of its $300 million Series C financing round which was led by Access Biotechnology with participation...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis represented Ping Identity, while Goodwin Procter represented Thoma Bravo in the transaction. Ping Identity (NYSE: PING), provider of the Intelligent Identity solution for...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised WiTricity, while Wiggin and Dana LLP acted for Siemens. WiTricity announced its receipt of a $25 million minority stake investment by Siemens. WiTricity is...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Apollo Intelligence on the deal. Apollo Intelligence announced its sale to Frazier Healthcare Partners. Apollo will continue to focus on elevating industry standards for...
You must be a Standard 1 Year member to access this content.
Goodwin advised Nuvig Therapeutics on the deal. Nuvig Therapeutics announced its $47 million Series A financing and the launch of the company to develop novel therapeutics that...
You must be a Standard 1 Year member to access this content.
Goodwin advised Gandeeva on the deal. Gandeeva announced its Series A funding led by Lux Capital and Leaps by Bayer, with participation from Obvious Ventures, Amgen Ventures,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Garuda Therapeutics on the deal. Garuda Therapeutics announced its launch and $72 million Series A financing led by Aisling Capital, Northpond Ventures, and OrbiMed,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Vida Ventures on the deal while Goodwin Procter represented Vigil Neuroscience. Vigil Neuroscience, a biotechnology company harnessing the power of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised the underwriters, while Latham & Watkins represented Rapid Micro Biosystems, Inc. in the offering. Rapid Micro Biosystems, Inc. (Nasdaq: RPID), an innovative life sciences...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised VRChat on the deal. VRChat announced its $80 Million Series D investment round. The financing was led by Anthos Capital, alongside existing investors...
You must be a Standard 1 Year member to access this content.
